[p53-mediated apoptosis].
Miyashita
T
T
Department of Genetics, National Children's Medical Research Center, Tokyo, Japan.
D017209:Apoptosis / Q000235:genetics; D018797:Cell Cycle Proteins; D004249:DNA Damage; D010450:Endopeptidases / Q000502:physiology; D058851:GPI-Linked Proteins; D016158:Genes, p53 / Q000502:physiology*; D006801:Humans; D007399:Interphase / Q000235:genetics; D008565:Membrane Proteins / Q000502:physiology; D009363:Neoplasm Proteins; D011518:Proto-Oncogene Proteins / Q000378:metabolism; D019253:Proto-Oncogene Proteins c-bcl-2; D014157:Transcription Factors / Q000502:physiology*; D016159:Tumor Suppressor Protein p53 / Q000502:physiology*; D051028:bcl-2-Associated X Protein; D019014:fas Receptor / Q000502:physiology
D018797:Cell Cycle Proteins; C102519:GML protein, human; D058851:GPI-Linked Proteins; D008565:Membrane Proteins; D009363:Neoplasm Proteins; D011518:Proto-Oncogene Proteins; D019253:Proto-Oncogene Proteins c-bcl-2; D014157:Transcription Factors; D016159:Tumor Suppressor Protein p53; D051028:bcl-2-Associated X Protein; D019014:fas Receptor; D010450:Endopeptidases; C080473:insulin-like growth factor binding protein-3 protease